Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers
about
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Association of knee injuries with accelerated knee osteoarthritis progression: data from the Osteoarthritis InitiativeFirst qualification study of serum biomarkers as indicators of total body burden of osteoarthritisNon-invasive and in vivo assessment of osteoarthritic articular cartilage: a review on MRI investigations.Semiquantitative Imaging Biomarkers of Knee Osteoarthritis Progression: Data From the Foundation for the National Institutes of Health Osteoarthritis Biomarkers ConsortiumBest performing definition of accelerated knee osteoarthritis: data from the Osteoarthritis Initiative.Alpha C-telopeptide of type I collagen is associated with subchondral bone turnover and predicts progression of joint space narrowing and osteophytes in osteoarthritis.3D osteoarthritic changes in TMJ condylar morphology correlates with specific systemic and local biomarkers of disease.Serological assessment of neutrophil elastase activity on elastin during lung ECM remodeling.Methodologic issues in clinical trials for prevention or risk reduction in osteoarthritisAnalysis on the serum levels of the biomarker CTX-II in professional indoor soccer players over the course of one seasonPredictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium.Investigating the Robustness and Diagnostic Potential of Extracellular Matrix Remodelling Biomarkers in Alkaptonuria.Recent findings on the role of gelatinases (matrix metalloproteinase-2 and -9) in osteoarthritisApplication of biomarkers in the development of drugs intended for the treatment of osteoarthritisAssociation between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort.Personalized medicine for osteoarthritis: where are we now?Value of biomarkers in osteoarthritis: current status and perspectives.Influence of acupuncture in treatment of knee osteoarthritis and cartilage repairingRepublished: Value of biomarkers in osteoarthritis: current status and perspectives.Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials.Proteomics of osteoarthritic chondrocytes and cartilage.Rheumatoid arthritis: a case for personalized health care?Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar.Investigational drugs for the treatment of osteoarthritis.Biomarkers: in combination they may do better.Diagnosis of osteoarthritis and prognosis of tibial cartilage loss by quantification of tibia trabecular bone from MRI.Serological biomarkers detect active joint destruction and inflammation in patients with haemophilic arthropathy.Scientific Opinion on the substantiation of a health claim related to glucosamine and maintenance of normal joint cartilage pursuant to Article 13(5) of Regulation (EC) No 1924/2006Metabolic analysis of knee synovial fluid as a potential diagnostic approach for osteoarthritis.Meta-analysis of urinary C-terminal telopeptide of type II collagen as a biomarker in osteoarthritis diagnosis.
P2860
Q27687777-AF2E23AC-18B9-4FB4-9D90-5C37AC5CE63EQ28396674-2B320772-C7B2-40F6-9F73-3C8D2EBC4DE9Q28748487-CE923CAF-B529-4F77-B790-B5839E5E0370Q30827809-B75E5673-16DB-43F2-82DA-FD5216F12D0EQ31084468-C95FAE91-A63C-40C9-8706-AAFF0B735FA8Q31135820-FF8A7541-6A0F-4120-945D-BE99AEFA8DA5Q34122276-5FF6349F-AED8-4A3B-9041-97D7EFB89E31Q34289651-C8A4B5BE-3A86-4C12-8407-0C838F1BC0ACQ35590577-357E7913-9DA1-4F05-A827-AACC33402001Q35678484-1935B0B2-29EA-4BF3-B8C1-ED17DCBECA81Q35901585-7933AFD9-69CB-48F7-ABFC-BC2315871DD4Q36050803-37874E37-98E7-48A9-866D-1BB734CA06E7Q36090540-95D36B47-F6A0-43EE-A833-7719EAD7622EQ36140890-9CF0F080-DF5F-4883-9AAC-D2C8D58BF2A6Q36598469-1CEC1AD3-E917-4EDF-BFBD-FF63003FD04FQ36758571-3F218AB3-A828-43B6-A12D-AABCE7842ECFQ36800983-A81F89D9-1DD9-4540-B1DC-073995FA188FQ37267571-3A5D6867-3985-4471-B1BC-CFA50DED5935Q37293187-788AD74B-1CF7-48CA-8900-1E7FD5D9AB54Q37602869-1DF6EB2F-FA59-4192-A917-F5B23407BB92Q37775799-F8489F55-71AB-4D97-BB5F-B82E428EB2BBQ37802877-314DCDA0-7CA2-494D-A92F-C196E1D2F2CAQ38182471-F0E79C42-C9C5-4396-89E8-94664984DCAFQ38218544-DEB4EEA0-8785-4ACB-9914-C70242265F97Q38597565-B0575356-87E6-417C-8792-5C0A7B6EAE56Q42693005-FFB840B0-6834-4D21-8885-C0E636D98271Q44812321-85A0BB15-94DC-429D-AA00-05072E20C190Q45867034-D691F580-8F9F-4043-B626-69A0947B47F6Q47151673-14A20FA8-0B88-46BE-8285-89829D1FC212Q53225145-4DB09F77-9541-4455-B68C-EA57F35864C0Q55096160-1E1F6E40-E652-4CF3-B49A-3D886A8846BF
P2860
Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of progressors ...... chemical and MRI-based markers
@en
Identification of progressors ...... hemical and MRI-based markers.
@nl
type
label
Identification of progressors ...... chemical and MRI-based markers
@en
Identification of progressors ...... hemical and MRI-based markers.
@nl
prefLabel
Identification of progressors ...... chemical and MRI-based markers
@en
Identification of progressors ...... hemical and MRI-based markers.
@nl
P2093
P2860
P356
P1476
Identification of progressors ...... chemical and MRI-based markers
@en
P2093
Arish A Qazi
Claus Christiansen
Erik B Dam
Inger Byrjalsen
Jenny Folkesson
Marco Loog
Morten A Karsdal
Paola C Pettersen
Patrick Garnero
P2860
P2888
P356
10.1186/AR2774
P50
P577
2009-07-24T00:00:00Z
P5875
P6179
1028729388